共 50 条
- [31] Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (10): : 653 - 662
- [32] Efficacy of finerenone in reducing heart failure outcomes in patients with history of heart failure: A meta-analysis of randomized controlled trials IJC HEART & VASCULATURE, 2024, 55
- [33] Effect of survodutide, a glucagon and GLP-1 receptor dual agonist, on weight loss: a meta-analysis of randomized controlled trials DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
- [37] Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
- [39] Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (10): : 776 - 785